iRhythm Technologies to Participate in Upcoming Investor Conferences
Rhea-AI Summary
iRhythm Technologies (NASDAQ: IRTC) announced management will present at four investor conferences in November–December 2025.
Scheduled presentations: Wolfe Research on Nov 18, 2025 at 9:20 AM ET; Jefferies on Nov 20, 2025 at 9:30 AM GMT; Citi on Dec 3, 2025 at 1:00 PM ET; and Evercore on Dec 4, 2025 at 9:10 PM ET. Live and archived webcasts will be available in the Events & Presentations section of the company investor website at investors.irhythmtech.com.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, IRTC declined 0.34%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences.
- Wolfe Research 2025 Healthcare Conference on Tuesday, November 18, 2025, at 9:20 a.m. Eastern Time (6:20 a.m. Pacific Time)
- Jefferies 2025 Global Healthcare Conference on Thursday, November 20, 2025, at 9:30 a.m. Greenwich Mean Time (1:30 a.m. Pacific Time)
- Citi 2025 Global Healthcare Conference on Wednesday, December 03, 2025, at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time)
- Evercore 8th Annual Healthcare Conference on Thursday, December 04, 2025, at 9:10 p.m. Eastern Time (6:10 a.m. Pacific Time)
Interested parties may access live and archived webcasts of the presentations on the “Events & Presentations” section of the company’s investor website at investors.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all. For additional information about iRhythm, please visit its corporate website at irhythmtech.com.
Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com
Media Contact
Kassandra Perry
irhythm@highwirepr.com